Welcome to our dedicated page for Balchem news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem stock.
Balchem Corporation reports developments tied to its specialty ingredient manufacturing business for health, nutrition, agriculture, healthcare, and other industrial markets. The company operates through Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, with recurring updates on segment sales, earnings, cash flow, debt, share repurchases, and conference participation.
Company news also includes product and market developments such as customized food and beverage ingredient systems, key nutrients for food, supplement, and pharmaceutical applications, animal nutrition products, choline chloride, specialty-packaged chemicals, and chelated minerals for micronutrient agriculture. Updates have included the Metalosate® T.E.A.M.™ plant tissue analysis platform and trade actions affecting choline chloride supply chains.
Balchem Corporation (BCPC) will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Chairman, President and CEO Ted Harris, CFO Martin Bengtsson and Senior Director of Investor Relations Allison Baurichter are scheduled to attend and represent the company.
Balchem (NASDAQ: BCPC) reported record second quarter 2026 results, with net sales of $284.0 million, up 11.2% year over year, GAAP net earnings of $44.6 million (+16.6%), adjusted EBITDA of $77.9 million (+12.6%), and free cash flow of $36.2 million.
GAAP EPS was $1.39 versus $1.17 and adjusted EPS was $1.49 versus $1.27 in the prior-year quarter. All three segments delivered higher sales: Human Nutrition and Health $176.9 million (+10.0%), Animal Nutrition and Health $64.5 million (+15.0%), and Specialty Products $40.5 million (+8.9%). Consolidated gross margin rose 11.4% to $103.7 million, with margin at 36.5%.
Balchem amended its revolving credit facility on July 24, 2026, extending maturity to July 24, 2031 and increasing borrowing capacity from $550 million to $650 million. The company repurchased $29 million of stock in Q2 and $114 million over the trailing twelve months, ended the quarter with net debt of $88.8 million and a net leverage ratio of 0.3x.
Balchem (NASDAQ: BCPC) will hold a quarterly conference call on Friday, July 31, 2026, at 11:00 AM ET to review its second quarter 2026 financial results. The company will release the results and financial exhibits before the market opens and post them on its website.
Institutional investors, analysts, and the public can join via dial-in or a live webcast, with a replay available online for one year.
Balchem (NASDAQ:BCPC), a global specialty ingredient manufacturer serving health and nutrition markets, announced participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Ted Harris, Martin Bengtsson, and Allison Baurichter are scheduled to represent the company.
Balchem (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, will participate in the Wells Fargo Industrials Conference on June 10, 2026.
Chairman, President and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter are scheduled to attend.
Balchem (NASDAQ: BCPC) reported Q1 2026 results for the quarter ended March 31, 2026: net sales $270.7M, GAAP net earnings $40.3M, adjusted EBITDA $74.3M, and free cash flow $33.8M. Gross margin rose to $101.1M (37.3% of sales). Company reported record Q1 sales, adjusted EBITDA, and net earnings, with growth across all three segments.
Cash balance was $72.9M; net debt $96.1M; dividend paid $30.8M and share repurchases $15.7M. A published clinical study using VitaCholine appears in Nutrients. Quarterly call scheduled April 30, 2026 at 11:00 AM ET.
Balchem (NASDAQ: BCPC) published its 2025 Sustainability Report on April 22, 2026, highlighting environmental and social progress. Key metrics: a 31% absolute reduction in Scope 1 and Scope 2 emissions vs 2020 (surpassing a 25% 2030 target), 16% water withdrawal reduction vs 2020, and external limited assurance for select emissions data.
The report notes alignment with the UN Global Compact, that ~75% of revenue supports specific UN SDGs, more than half of facilities have five+ consecutive injury-free years, and completion of double materiality and climate risk assessments.
Balchem (NASDAQ: BCPC) will host a conference call on April 30, 2026 at 11:00 AM ET to review first quarter 2026 results. First quarter results and financial exhibits will be published prior to market open on April 30, 2026 and posted on the company website.
Management participants include Ted Harris, Chairman, President and CEO, and Martin Bengtsson, CFO. A live webcast and a one-year replay will be available to investors and the public.
Balchem (NYSE:BCPC) launched the Metalosate® T.E.A.M.™ digital plant tissue analysis platform on March 9, 2026 to translate tissue data into actionable micronutrient recommendations for specialty crops. Free for U.S. pest control advisors and agronomists, T.E.A.M. evaluates nutrient concentrations versus crop-specific optimal ranges and archives historical data for trend tracking.
Balchem (NASDAQ: BCPC) will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Company executives Ted Harris (Chairman, President & CEO), Martin Bengtsson (CFO) and Allison Baurichter (Senior Director Investor Relations) will attend and speak.